JP Morgan Initiates Coverage On Neurogene with Overweight Rating, Announces Price Target of $60

Benzinga · 1d ago
JP Morgan analyst Priyanka Grover initiates coverage on Neurogene (NASDAQ:NGNE) with a Overweight rating and announces Price Target of $60.